These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22469872)

  • 1. Patient registry of outcomes in spasticity care.
    Esquenazi A; Mayer N; Lee S; Brashear A; Elovic E; Francisco GE; Yablon S;
    Am J Phys Med Rehabil; 2012 Sep; 91(9):729-46. PubMed ID: 22469872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience.
    Esquenazi A; Lee S; Mayer N; Garreta R; Patel A; Elovic E; Koelbel S; Francisco G; Reuter I;
    Am J Phys Med Rehabil; 2017 Dec; 96(12):881-888. PubMed ID: 28657917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
    Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study.
    Francisco GE; Jost WH; Bavikatte G; Bandari DS; Tang SFT; Munin MC; Largent J; Adams AM; Zuzek A; Esquenazi A
    PM R; 2020 Nov; 12(11):1120-1133. PubMed ID: 31953896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.
    Esquenazi A; Bavikatte G; Bandari DS; Jost WH; Munin MC; Tang SFT; Largent J; Adams AM; Zuzek A; Francisco GE
    PM R; 2021 Oct; 13(10):1079-1093. PubMed ID: 33151636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of spastic upper limb with botulinum toxin].
    Dénes Z; Fehér M; Várkonyi A
    Ideggyogy Sz; 2007 May; 60(5-6):245-50. PubMed ID: 17578272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring spasticity and fine motor control (pinch) change in the hand after botulinum toxin-A injection using dynamic computerized hand dynamometry.
    Barden HL; Baguley IJ; Nott MT; Chapparo C
    Arch Phys Med Rehabil; 2014 Dec; 95(12):2402-9. PubMed ID: 24909588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
    Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
    NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience in using xeomin in the treatment of arm and hand spasticity in the early rehabilitation phase of stroke].
    Kostenko EV; Petrova LV; Ganzhula PA; Lisenker LN; Otcheskaia OV; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):29-34. PubMed ID: 22677662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
    Schramm A; Ndayisaba JP; Auf dem Brinke M; Hecht M; Herrmann C; Huber M; Lobsien E; Mehnert S; Reuter I; Stenner A; van der Ven C; Winterholler M; Kupsch A; Wissel J
    J Neural Transm (Vienna); 2014 May; 121(5):521-30. PubMed ID: 24407377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound and electrical stimulator-guided obturator nerve block with phenol in the treatment of hip adductor spasticity in long-term care patients: a randomized, triple blind, placebo controlled study.
    Lam K; Wong D; Tam CK; Wah SH; Myint MW; Yu TK; So KK; Cheung G; Au KM; Fu MH; Wu YM; Kng CP
    J Am Med Dir Assoc; 2015 Mar; 16(3):238-46. PubMed ID: 25458446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.